The funny thing is, no one expected the other arms-length acquisitions to happen, except in the case of Colotraq which got undone. Now, at least these "acquisitions" will probably close since it's Jakobs that's selling them.
Too bad we don't know what their financials look like. As if they had any in the case of this latest one that just became a company back in March..
News 
Market Data 
Discover 
